Ponezumab
Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease. Ponezumab was developed by Pfizer Inc. In November 2011 Pfizer halted the development of ponezumab after finishing a phase 2 trial.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1286826208 under CC BY-SA 4.0; modifications have been made.